Nail psoriasis affects a significant proportion of patients with psoriasis, but it represents one of the disease's most ...
Across a number of studies, researchers have found that following a Mediterranean-style diet—which includes olive oil and ...
Add Yahoo as a preferred source to see more of our stories on Google. It’s important to pay attention to changes in your body, including new symptoms, because the earlier comorbidities are caught, the ...
If you’ve just been diagnosed with psoriasis, you’re far from alone: 125 million people worldwide have this condition, with over 8 million in the U.S. alone. Psoriasis is a chronic autoimmune ...
Gelfand, MD, of the University of Pennsylvania in Philadelphia, highlighted the growing recognition of psoriasis as a ...
Everyday Health on MSN
Biologics for psoriasis: Are dual inhibitors more effective?
Learn how biologic therapies for psoriasis work, the difference between single and dual inhibitors, and how dermatologists choose the right treatment for the individual.
A therapy that works similarly to AbbVie’s blockbuster Skyrizi appeared more potent in a mid-stage trial and has the ...
Psoriasis vulgaris is the most common form of psoriasis. It causes patches of scaly, inflamed skin and can occur across the body. Vulgaris is Latin for ‘common’, so it means a common form of psoriasis ...
Scalp Psoriasis vs. Dandruff: What’s the Difference? This article was reviewed by Knox Beasley, MD. If you’re experiencing a flaking, itching scalp, you may do a quick self-diagnosis of dandruff. But ...
Stocktwits on MSN
ORKA stock is soaring after psoriasis trial results — here's why BTIG hiked its price target by 94%
BTIG added that updated Phase 1 PK/PD data also suggest ORKA-001 could enable once-yearly maintenance dosing, which the firm believes would be a first for any monoclonal antibody. ・The firm raised its ...
Three years after AbbVie stood at the edge of a major patent cliff with the loss of exclusivity for immunology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results